AU7913387A - A new system for administration of liposomes to mammals - Google Patents

A new system for administration of liposomes to mammals

Info

Publication number
AU7913387A
AU7913387A AU79133/87A AU7913387A AU7913387A AU 7913387 A AU7913387 A AU 7913387A AU 79133/87 A AU79133/87 A AU 79133/87A AU 7913387 A AU7913387 A AU 7913387A AU 7913387 A AU7913387 A AU 7913387A
Authority
AU
Australia
Prior art keywords
liposomes
mammals
administration
new system
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU79133/87A
Other versions
AU603139B2 (en
Inventor
Bengt Ingemar Axelsson
Ulla Katarina Bystrom
Carl Magnus Olof Dahlback
Leif Arne Kallstrom
Per-Gunnar Nilsson
Jan William Trofast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Draco AB
Original Assignee
Draco AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco AB filed Critical Draco AB
Publication of AU7913387A publication Critical patent/AU7913387A/en
Application granted granted Critical
Publication of AU603139B2 publication Critical patent/AU603139B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU79133/87A 1986-09-12 1987-09-08 A new system for administration of liposomes to mammals Ceased AU603139B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8603812 1986-09-12
SE8603812A SE8603812D0 (en) 1986-09-12 1986-09-12 ADMINISTRATION OF LIPOSOMES TO MAMMALS

Publications (2)

Publication Number Publication Date
AU7913387A true AU7913387A (en) 1988-04-07
AU603139B2 AU603139B2 (en) 1990-11-08

Family

ID=20365554

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79133/87A Ceased AU603139B2 (en) 1986-09-12 1987-09-08 A new system for administration of liposomes to mammals

Country Status (13)

Country Link
EP (2) EP0260241A1 (en)
JP (1) JPH01500668A (en)
KR (1) KR880701540A (en)
AU (1) AU603139B2 (en)
CA (1) CA1256798A (en)
DK (1) DK247388D0 (en)
FI (1) FI882221A (en)
HU (1) HU198835B (en)
IE (1) IE872453L (en)
NZ (1) NZ221732A (en)
SE (1) SE8603812D0 (en)
WO (1) WO1988001862A1 (en)
ZA (1) ZA876641B (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05507090A (en) * 1990-05-08 1993-10-14 リポサーム　テクノロジー　インコーポレイテッド Direct spray-dried drug/lipid powder compositions
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
SE9003100D0 (en) * 1990-09-28 1990-09-28 Kabivitrum Ab LIPID FORMULATION SYSTEM
ATE137959T1 (en) * 1992-02-12 1996-06-15 Janssen Cilag S P A LIPOSOMAL PIROXYCAM FORMULATION
WO1993015718A1 (en) * 1992-02-12 1993-08-19 Janssen Farmaceutici S.P.A. Liposomal piroxicam formulations
SE9200951D0 (en) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab PHARMACEUTICAL COMPOSITION CONTAINING A DEFINED LIPID SYSTEM
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
SA95160463B1 (en) * 1994-12-22 2005-10-04 استرا أكتيبولاج powders for inhalation
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
GB9501286D0 (en) * 1995-01-24 1995-03-15 Ciba Geigy Ag Pharmaceutical compositions and preparations thereof
WO1996026726A1 (en) * 1995-02-28 1996-09-06 Hoechst Marion Roussel, Inc. Pharmaceutical composition for piperidinoalkanol compounds
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
TW497974B (en) * 1996-07-03 2002-08-11 Res Dev Foundation High dose liposomal aerosol formulations
US5958378A (en) * 1996-07-03 1999-09-28 Research Development Foundation High dose liposomal aerosol formulations containing cyclosporin A or budesonide
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6599889B2 (en) * 1997-12-24 2003-07-29 Methylgere, Inc. Acyl phosphonate inhibitors of β-lactamases
US6608046B1 (en) * 1997-12-24 2003-08-19 Methylgene, Inc. β-lactamase and DD-peptidase inhibitors
DE69930259T2 (en) * 1998-05-27 2006-11-23 Euro-Celtique S.A. COMPOSITIONS FOR THE USE OF INFLAMMATORY INHIBITORS, ESPECIALLY ANTISEPTIC AND / OR WOUND HEALING AGENTS IN THE UPPER RESPONSE AND / OR EAR
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
GB9902527D0 (en) * 1999-02-04 1999-03-24 Phares Pharm Res Nv Compositions
US6630169B1 (en) 1999-03-31 2003-10-07 Nektar Therapeutics Particulate delivery systems and methods of use
US7364749B1 (en) 1999-05-27 2008-04-29 Euro-Celtique, S.A. Preparations for the application of anti-infective and/or anti-inflammatory agents
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
BR0010983A (en) 1999-05-27 2002-03-05 Euro Celtique Sa Preparations for the application of anti-inflammatory agents
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
US6676930B2 (en) 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1296651E (en) 2000-06-27 2008-02-12 Vectura Ltd Method of making particles for use in a pharmaceutical composition
AU2001269261B2 (en) * 2000-06-27 2005-11-17 Vectura Limited Method of making particles for use in a pharmaceutical composition
US7141236B2 (en) 2000-07-28 2006-11-28 Nektar Therapeutics Methods and compositions for delivering macromolecules to or via the respiratory tract
JP2004528339A (en) * 2001-04-26 2004-09-16 ネクター セラピューティクス Novel methods and compositions for delivering macromolecules to or through the respiratory tract
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
CA2627657A1 (en) * 2005-10-26 2007-05-03 Yissum Research Development Company Of The Hebrew University Of Jerusal Em A method for preparing liposomes and uses thereof
WO2009073843A1 (en) * 2007-12-06 2009-06-11 Cytotech Labs, Llc Inhalable compositions having enhanced bioavailability
PL2544663T3 (en) 2010-03-12 2018-09-28 Berg Llc Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
EP3175844A1 (en) 2010-04-09 2017-06-07 Pacira Pharmaceuticals, Inc. Large diameter synthetic membrane vesicles
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
US20130209550A1 (en) 2010-07-28 2013-08-15 Life Technologies Corporation Anti-Viral Azide Containing Compounds
CN103732214B (en) 2011-06-17 2017-04-12 博格有限责任公司 Inhalable pharmaceutical compositions
KR20140129054A (en) 2012-01-26 2014-11-06 라이프 테크놀로지스 코포레이션 Methods for increasing the infectivity of viruses
HU231309B1 (en) 2014-02-25 2022-11-28 Darholding Kft. Compositions comprising indometacine, its pharmaceutically acceptable salts and cocrystals; and process for the preparation
CN111729087A (en) * 2020-07-24 2020-10-02 成都大学 Lipid modifier of selective beta 2 receptor agonist and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
GB1575344A (en) * 1978-03-03 1980-09-17 Ici Ltd Method for the manufacture of liposome composition
JPH0753661B2 (en) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ Pro-liposome composition and method of making an aqueous dispersion of liposomes
WO1986006959A1 (en) * 1985-05-22 1986-12-04 Liposome Technology, Inc. Liposome inhalation method and system

Also Published As

Publication number Publication date
WO1988001862A1 (en) 1988-03-24
KR880701540A (en) 1988-11-03
IE872453L (en) 1988-03-12
NZ221732A (en) 1990-08-28
AU603139B2 (en) 1990-11-08
JPH01500668A (en) 1989-03-09
HUT47840A (en) 1989-04-28
ZA876641B (en) 1988-03-14
EP0282537A1 (en) 1988-09-21
CA1256798A (en) 1989-07-04
DK247388A (en) 1988-05-06
DK247388D0 (en) 1988-05-06
EP0260241A1 (en) 1988-03-16
FI882221A0 (en) 1988-05-11
HU198835B (en) 1989-12-28
SE8603812D0 (en) 1986-09-12
FI882221A (en) 1988-05-11

Similar Documents

Publication Publication Date Title
AU7913387A (en) A new system for administration of liposomes to mammals
AU560956B2 (en) Preparation of hyaluronic acid
AU4094685A (en) Interleukin administration via liposomes
AU2026788A (en) Registration of a new cordless telephone to an existing system
AU591152B2 (en) Devices for administering medicaments to patients
AU589075B2 (en) System of modular construction for a covered structure
EP0186352A3 (en) Preparation of lipid vesicles
EP0223513A3 (en) A process for preparation of cyclopolydiorganosiloxanes
AU7957887A (en) Pervaporation of phenols
AU7824387A (en) A method of forming a fixed structure
AU6370686A (en) Retardation preparation for a medicine
AU573085B2 (en) Production of monotertiarybutyl toluinediamines
AU8092587A (en) Synthesis of purin-9-ylalkylenoxymethyl phosphonic acids
ZA867982B (en) A process for the preparation of sodium amoxycillin
ZA875174B (en) A method for the preparation of a therapeutically active compound
AU1873388A (en) Preparation of a piperidinylcyclopentylheptenoic acid derivative
AU603846B2 (en) Method for preparation of mercaptobenzoates
AU2012888A (en) Preparation of a new diosmine derivative
PT84299A (en) Process for the preparation of a pharmacologically active compound of substituted oxodiazine
AU6830187A (en) Method to build framework constructions
AU3936885A (en) Fuel-vaporizing system of carburetion
AU588633B2 (en) Improvements to formwork
AU598737B2 (en) Improvements relating to chairs
AU7307487A (en) Method of operating a system
GB8526630D0 (en) Preparation of quinones